P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844688.25652.68 |
| _version_ | 1797285923167141888 |
|---|---|
| author | U. Pakulska N. Angelosanto M. Mikula H. Nogai R. Dudziak C. Abboud M. Obacz K. Goller M. Cybulska M. Mazan M. Kozakowska T. Rzymski |
| author_facet | U. Pakulska N. Angelosanto M. Mikula H. Nogai R. Dudziak C. Abboud M. Obacz K. Goller M. Cybulska M. Mazan M. Kozakowska T. Rzymski |
| author_sort | U. Pakulska |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:10:56Z |
| format | Article |
| id | doaj.art-3a974211f30d4cd7896a690762c3d7ce |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:10:56Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-3a974211f30d4cd7896a690762c3d7ce2024-03-02T07:47:19ZengWileyHemaSphere2572-92412022-06-01635035110.1097/01.HS9.0000844688.25652.68202206003-00350P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDSU. Pakulska0N. Angelosanto1M. Mikula2H. Nogai3R. Dudziak4C. Abboud5M. Obacz6K. Goller7M. Cybulska8M. Mazan9M. Kozakowska10T. Rzymski111 R&D2 Clinical Department, Ryvu Therapeutics, Kraków3 Maria Skłodowska-Curie Institute - Cancer Center, Warsaw, Poland2 Clinical Department, Ryvu Therapeutics, Kraków2 Clinical Department, Ryvu Therapeutics, Kraków4 Washington University School of Medicine in St. Louis, St Louis, United States of America1 R&D1 R&D3 Maria Skłodowska-Curie Institute - Cancer Center, Warsaw, Poland1 R&D1 R&D1 R&Dhttp://journals.lww.com/10.1097/01.HS9.0000844688.25652.68 |
| spellingShingle | U. Pakulska N. Angelosanto M. Mikula H. Nogai R. Dudziak C. Abboud M. Obacz K. Goller M. Cybulska M. Mazan M. Kozakowska T. Rzymski P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS HemaSphere |
| title | P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS |
| title_full | P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS |
| title_fullStr | P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS |
| title_full_unstemmed | P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS |
| title_short | P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS |
| title_sort | p450 preclinical and clinical signs of rvu120 efficacy a specific cdk8 19 inhibitor in dnmt3a mutation positive aml and hr mds |
| url | http://journals.lww.com/10.1097/01.HS9.0000844688.25652.68 |
| work_keys_str_mv | AT upakulska p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT nangelosanto p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT mmikula p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT hnogai p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT rdudziak p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT cabboud p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT mobacz p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT kgoller p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT mcybulska p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT mmazan p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT mkozakowska p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds AT trzymski p450preclinicalandclinicalsignsofrvu120efficacyaspecificcdk819inhibitorindnmt3amutationpositiveamlandhrmds |